185 related articles for article (PubMed ID: 16861916)
1. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers.
Li QX; Zhao J; Liu JY; Jia LT; Huang HY; Xu YM; Zhang Y; Zhang R; Wang CJ; Yao LB; Chen SY; Yang AG
Cancer Biol Ther; 2006 Jul; 5(7):860-6. PubMed ID: 16861916
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression.
Wang R; Lin F; Wang X; Gao P; Dong K; Wei SH; Cheng SY; Zhang HZ
Cancer Biol Ther; 2007 Aug; 6(8):1295-301. PubMed ID: 17712228
[TBL] [Abstract][Full Text] [Related]
3. Short hairpin RNA targeting survivin inhibits growth and angiogenesis of glioma U251 cells.
Zhen HN; Li LW; Zhang W; Fei Z; Shi CH; Yang TT; Bai WT; Zhang X
Int J Oncol; 2007 Nov; 31(5):1111-7. PubMed ID: 17912437
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
5. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
[TBL] [Abstract][Full Text] [Related]
7. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer.
Tu SP; Jiang XH; Lin MC; Cui JT; Yang Y; Lum CT; Zou B; Zhu YB; Jiang SH; Wong WM; Chan AO; Yuen MF; Lam SK; Kung HF; Wong BC
Cancer Res; 2003 Nov; 63(22):7724-32. PubMed ID: 14633697
[TBL] [Abstract][Full Text] [Related]
8. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest.
He SQ; Rehman H; Gong MG; Zhao YZ; Huang ZY; Li CH; Zhang WG; Chen XP
Cancer Biol Ther; 2007 Aug; 6(8):1247-57. PubMed ID: 17700059
[TBL] [Abstract][Full Text] [Related]
10. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
Hou JQ; He J; Wang XL; Wen DG; Chen ZX
Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.
Uchida H; Tanaka T; Sasaki K; Kato K; Dehari H; Ito Y; Kobune M; Miyagishi M; Taira K; Tahara H; Hamada H
Mol Ther; 2004 Jul; 10(1):162-71. PubMed ID: 15233951
[TBL] [Abstract][Full Text] [Related]
12. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
13. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells.
Zhang HZ; Wang Y; Gao P; Lin F; Liu L; Yu B; Ren JH; Zhao H; Wang R
Cancer Biol Ther; 2006 Nov; 5(11):1457-61. PubMed ID: 17012855
[TBL] [Abstract][Full Text] [Related]
14. p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression.
Kim SH; Singh SV
Cancer Prev Res (Phila); 2010 Jun; 3(6):718-26. PubMed ID: 20484174
[TBL] [Abstract][Full Text] [Related]
15. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
Sun HB; Zheng HY; Yan X
Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
[TBL] [Abstract][Full Text] [Related]
16. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
Yang W; Sun T; Cao J; Liu F
Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
[TBL] [Abstract][Full Text] [Related]
17. [siRNA against survivin coupling with epirubicin enhances to induce breast cancer cell MCF-7 to apoptosis].
Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):221-5. PubMed ID: 16608080
[TBL] [Abstract][Full Text] [Related]
18. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
Nakao K; Hamasaki K; Ichikawa T; Arima K; Eguchi K; Ishii N
Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
[TBL] [Abstract][Full Text] [Related]
19. [Effects of survivin small interfering RNA on biological behaviors of bladder cancer T24 cells].
Wang XL; Hou JQ; Wen DG; He J
Ai Zheng; 2008 Mar; 27(3):253-7. PubMed ID: 18334113
[TBL] [Abstract][Full Text] [Related]
20. Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.
George J; Banik NL; Ray SK
Neuro Oncol; 2010 Nov; 12(11):1088-101. PubMed ID: 20679253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]